CN1406280A - 祖细胞保护因子和相关的方法和产物 - Google Patents

祖细胞保护因子和相关的方法和产物 Download PDF

Info

Publication number
CN1406280A
CN1406280A CN99817102A CN99817102A CN1406280A CN 1406280 A CN1406280 A CN 1406280A CN 99817102 A CN99817102 A CN 99817102A CN 99817102 A CN99817102 A CN 99817102A CN 1406280 A CN1406280 A CN 1406280A
Authority
CN
China
Prior art keywords
cells
fril
cell
population
progenitor cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99817102A
Other languages
English (en)
Chinese (zh)
Inventor
M·G·科卢西
M·J·克里斯皮尔斯
J·G·穆尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
Floggix GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Floggix GmbH filed Critical Floggix GmbH
Publication of CN1406280A publication Critical patent/CN1406280A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
CN99817102A 1999-12-30 1999-12-30 祖细胞保护因子和相关的方法和产物 Pending CN1406280A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/031307 WO2001049851A1 (en) 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products

Publications (1)

Publication Number Publication Date
CN1406280A true CN1406280A (zh) 2003-03-26

Family

ID=22274423

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99817102A Pending CN1406280A (zh) 1999-12-30 1999-12-30 祖细胞保护因子和相关的方法和产物

Country Status (10)

Country Link
EP (1) EP1246919B1 (enExample)
JP (1) JP2003521900A (enExample)
CN (1) CN1406280A (enExample)
AT (1) ATE302848T1 (enExample)
AU (1) AU784361C (enExample)
CA (1) CA2395625A1 (enExample)
DE (1) DE69926920T2 (enExample)
ES (1) ES2249058T3 (enExample)
HK (1) HK1050027B (enExample)
WO (1) WO2001049851A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
JP4394350B2 (ja) 2001-01-09 2010-01-06 ベイラー リサーチ インスティテュート 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
WO2002067973A1 (en) * 2001-02-27 2002-09-06 Phylogix Llc Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues
CN101415434A (zh) * 2003-11-12 2009-04-22 晨兴风险投资有限公司 用于治疗b细胞淋巴瘤和其它癌症的方法和组合物
WO2006110577A2 (en) * 2005-04-08 2006-10-19 Morningside Venture Investments Limited Use of fril proteins for reducing the production of pro-inflammatory cytokines
EP2108043A4 (en) 2007-01-18 2010-04-21 Suomen Punainen Risti Veripalv NEW METHODS AND REAGENTS FOR THE PRODUCTION OF CELLS
US11083190B2 (en) 2007-06-29 2021-08-10 Makoto Funaki Soft gel systems in modulating stem cell development
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6247472B2 (ja) * 2013-08-06 2017-12-13 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
CN114262683B (zh) * 2022-03-01 2022-06-17 中国科学院动物研究所 一种表达vegfr3 d2多肽的细菌制剂及其构建方法和应用
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455678B1 (en) * 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen
US6084060A (en) * 1996-12-09 2000-07-04 Imclone Systems Incorporated Composition and method for preserving progenitor cells
US6310195B1 (en) * 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor

Also Published As

Publication number Publication date
HK1050027B (en) 2006-04-13
EP1246919B1 (en) 2005-08-24
HK1050027A1 (en) 2003-06-06
WO2001049851A1 (en) 2001-07-12
AU784361B2 (en) 2006-03-16
DE69926920T2 (de) 2006-06-29
DE69926920D1 (de) 2005-09-29
JP2003521900A (ja) 2003-07-22
EP1246919A1 (en) 2002-10-09
AU784361C (en) 2007-03-15
ES2249058T3 (es) 2006-03-16
ATE302848T1 (de) 2005-09-15
CA2395625A1 (en) 2001-07-12
AU2401400A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
CN1174996C (zh) 干细胞增殖抑制剂和刺激剂及其用途
EP1017789B1 (en) Nucleic acid encoding a lectin-derived progenitor cell preservation factor
AU784361B2 (en) Progenitor cell preservation factors and related methods and products
CN1150318C (zh) 用于预防或治疗恶性肿瘤的HER-2/neu蛋白胞内区
CN1171819A (zh) 分泌产生血小板生成素多肽的方法
CN1148408A (zh) 血细胞生成蛋白及其制造材料和方法
CN101065400A (zh) 用于治疗性应用的经遗传改变的细胞
CN101080487A (zh) 成熟树突细胞组合物及其培养方法
CN1839202A (zh) 细胞毒性淋巴细胞的制备方法
CN1124348C (zh) 多功能性造血受体激动剂
CN1681836A (zh) 递送治疗或诊断试剂的导向蛋白质
CN1503677A (zh) 用lp82治疗造血障碍
CN1173136A (zh) 用造血蛋白刺激红细胞生成的方法
CN1620498A (zh) 用于体外分离和培养具有种系传递能力的胚胎干细胞(es)细胞系的组合物
CN1171791A (zh) 纯化的血小板生成素及其制造方法
US6991794B1 (en) Progenitor cell preservation factors and methods for and products of their use
CN1076356C (zh) 具有血小板生成素活性的蛋白质
CN1901932A (zh) 细胞因子拮抗剂分子
CN1230993A (zh) 制备血小板生成素多肽的表达载体、细胞和方法
CN1802169A (zh) Bv8和/或EG－VEGF促进造血的用途
DE DK et al. NUKLEINSÄURE, WELCHE EINEN VON LEKTIN ABSTAMMENDEN FAKTOR ZUR PRÄSERVIERUNG VON PROGENITORZELLEN KODIERT ACIDE NUCLEIQUE CODANT UN FACTEUR DE CONSERVATION DE CELLULES PROGENITRICES DERIVE DE LA LECTINE
EP1584686A1 (en) Progenitor cell preservation factors and related methods and products
CN1774499A (zh) 一种设备
HK1084413A (en) Progenitor cell preservation factors and related methods and products
HK1005653A1 (en) A chemically modified methioninase and use of the same in anti-methionine and anti-homocysteine chemotherapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: IMMUNE CLONE SYSTEM CO., LTD.

Effective date: 20041126

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Free format text: FORMER OWNER: PHYLOGIX

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20041126

Address after: American California

Applicant after: The Regents of the University of California

Co-applicant after: Immune clonal system, Limited by Share Ltd

Address before: Maine

Applicant before: Phylogix

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20030326